In conclusion, the elucidation of TGFβ signaling as a brake for myoblast fusion opens new avenues to study this fundamental cellular process at a molecular level and to understand how fusion is perturbed in neuromuscular diseases. Here, TGFB1 is linked to neuromuscular disease.